These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6151160)

  • 1. Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation.
    Pomerleau OF; Pomerleau CS
    Neurosci Biobehav Rev; 1984; 8(4):503-13. PubMed ID: 6151160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking.
    Pomerleau OF
    Am J Med; 1992 Jul; 93(1A):2S-7S. PubMed ID: 1353943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroregulatory effects of nicotine.
    Pomerleau OF; Rosecrans J
    Psychoneuroendocrinology; 1989; 14(6):407-23. PubMed ID: 2560221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural pharmacology of nicotine: multiple mechanisms.
    Stolerman IP
    Br J Addict; 1991 May; 86(5):533-6. PubMed ID: 1650269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.
    Germeroth LJ; Baker NL; Saladin ME
    Addict Behav; 2018 Sep; 84():13-19. PubMed ID: 29597136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in performance without nicotine withdrawal.
    Warburton DM; Arnall C
    Psychopharmacology (Berl); 1994 Aug; 115(4):539-42. PubMed ID: 7871099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine and endogenous opioids: neurochemical and pharmacological evidence.
    Hadjiconstantinou M; Neff NH
    Neuropharmacology; 2011 Jun; 60(7-8):1209-20. PubMed ID: 21108953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain characteristics and nicotine deprivation as predictors of performance during a laboratory paradigm of smoking cessation.
    Powers JM; LaRowe LR; Heckman BW; Ditre JW
    Psychol Addict Behav; 2020 Mar; 34(2):341-350. PubMed ID: 31750703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bupropion on nicotine craving and withdrawal.
    Shiffman S; Johnston JA; Khayrallah M; Elash CA; Gwaltney CJ; Paty JA; Gnys M; Evoniuk G; DeVeaugh-Geiss J
    Psychopharmacology (Berl); 2000 Jan; 148(1):33-40. PubMed ID: 10663415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Configurations of the interoceptive discriminative stimulus effects of ethanol and nicotine with two different exteroceptive contexts in rats: Extinction & recovery.
    Troisi JR; Craig EM
    Behav Processes; 2015 Jun; 115():169-80. PubMed ID: 25895858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery.
    Smolka MN; Bühler M; Klein S; Zimmermann U; Mann K; Heinz A; Braus DF
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):577-88. PubMed ID: 16133128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioids and smoking: a review of progress and problems.
    Pomerleau OF
    Psychoneuroendocrinology; 1998 Feb; 23(2):115-30. PubMed ID: 9621393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nicotine dose and sensory cues in the regulation of smoke intake.
    Rose JE; Behm FM; Levin ED
    Pharmacol Biochem Behav; 1993 Apr; 44(4):891-900. PubMed ID: 8469698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.
    Chaudhri N; Caggiula AR; Donny EC; Palmatier MI; Liu X; Sved AF
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):353-66. PubMed ID: 16240165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal.
    Watkins SS; Koob GF; Markou A
    Nicotine Tob Res; 2000 Feb; 2(1):19-37. PubMed ID: 11072438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence.
    Smolka MN; Budde H; Karow AC; Schmidt LG
    Psychopharmacology (Berl); 2004 Sep; 175(3):374-81. PubMed ID: 15114432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nicotine dependence].
    Lebargy F
    Rev Pneumol Clin; 2000 Jun; 56(3):177-83. PubMed ID: 10880944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of tobacco dependence.
    Jarvik ME; Henningfield JE
    Pharmacol Biochem Behav; 1988 May; 30(1):279-94. PubMed ID: 3051049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine-produced antinociception in minimally deprived smokers and ex-smokers.
    Fertig JB; Pomerleau OF; Sanders B
    Addict Behav; 1986; 11(3):239-48. PubMed ID: 3739811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.